This was originally published in entirety on The Deal.
Genzeon, a healthcare solutions company headquartered in Exton, Pa., is expanding its artificial intelligence capabilities while keeping an eye toward M&A.
Founded in 2012, Genzeon develops technology products for payers, providers, healthcare product companies and life sciences organizations, including clinical research services companies.
The company has developed around 30 products, including a physician co-pilot platform that aids in diagnosis and a product focused on neonatal treatment for hospitals.
Despite significant interest from private equity firms, Genzeon remains privately held and is committed to organic growth.
“As of today, we are heads down, focused on building our company and reinvesting in building the company,” said CEO Ilanko Kumaresan, who joined 18 months ago. “We are not ready.”
But Kumaresan didn’t rule out the possibility of future investment.
“I mean, never say never … maybe in the future, a couple of years down the line, maybe we’ll be ready to have a conversation,” he said.
Kumaresan aims to keep up the company’s double-digit annual growth rate in the coming years.
Read the whole story at The Deal